Загрузка...
Все видеоНовые видеоПопулярные видео

Ravi Vij in Discussion with Dr. Jorge Castillo MD, on Waldenstrom Macroglobinemia

Ravi Vij in Discussion with Dr. Jorge Castillo MD, Assistant Professor of Medicine, Dana Farber Cancer Institute, Boston, MA: on Waldenstrom Macroglobinemia

Видео Ravi Vij in Discussion with Dr. Jorge Castillo MD, on Waldenstrom Macroglobinemia канала MyCancerHaven for Healthcare Professionals
Waldenstrom Macroglobinemia waldenstrom macroglobinemia myeloma cancer cancer supoort
Комментарии отсутствуют
Информация о видео
11 марта 2024 г. 18:42:02
00:23:44
MyCancerHaven for Healthcare Professionals
Теги
Правообладателям
Жалоба на материал Недопустимый материал Нарушение авторских прав
Комментарии
Поделиться
Другие видео канала

Ravi Vij, in Discussion with Dr. Hua-Jay "Jeff" Cherng, MD On Approacing Front-Line Treatment DLBCLRavi Vij, in Discussion with Dr. Hua-Jay "Jeff" Cherng, MD On Approacing Front-Line Treatment DLBCL

Ravi Vij, in Discussion with Dr. Saad Z. Usmani, On The Phase 3 CEPHEUS StudyRavi Vij, in Discussion with Dr. Saad Z. Usmani, On The Phase 3 CEPHEUS Study

Ravi Vij, in Discussion with Dr. Cristina Gasparetto, MD on Using Selinexor in the PracticeRavi Vij, in Discussion with Dr. Cristina Gasparetto, MD on Using Selinexor in the Practice

Ravi Vij, in Discussion with Dr. David Dingli, M.D. PhD, On Managing POEMS SyndromeRavi Vij, in Discussion with Dr. David Dingli, M.D. PhD, On Managing POEMS Syndrome

1B | A MyCancerHaven™ Expert Roundtable: New Insights on Maintenance Therapy for (NDMM)1B | A MyCancerHaven™ Expert Roundtable: New Insights on Maintenance Therapy for (NDMM)

2B | A MyCancerHaven™ Expert Roundtable:The Evolution of MM: Selecting Treatment After 3rd Relapse2B | A MyCancerHaven™ Expert Roundtable:The Evolution of MM: Selecting Treatment After 3rd Relapse

Ravi Vij in Discussion with Dr. Al-Ola A Abdallah, MD on Using CAR-T Cells Post 1st Relapse in MMRavi Vij in Discussion with Dr. Al-Ola A Abdallah, MD on Using CAR-T Cells Post 1st Relapse in MM

Ravi Vij in Discussion With Dr. Jesus Gonzalez Lugo, MD, on MDS: How He Intend to Use ImetelstatRavi Vij in Discussion With Dr. Jesus Gonzalez Lugo, MD, on MDS: How He Intend to Use Imetelstat

Ravi Vij, in Discussion with Dr. Adam Kittai MD on The Chronic Lymphocytic Leukemia (CLL) TreatmentRavi Vij, in Discussion with Dr. Adam Kittai MD on The Chronic Lymphocytic Leukemia (CLL) Treatment

3B | A MyCancerHaven™ Expert Roundtable: Navigating Treatment in First Through Third Relapse.3B | A MyCancerHaven™ Expert Roundtable: Navigating Treatment in First Through Third Relapse.

Ravi Vij in discussion with Dr. Nelson Leung on Myeloma & The KidneysRavi Vij in discussion with Dr. Nelson Leung on Myeloma & The Kidneys

2C | A MyCancerHaven™ Expert Roundtable: Navigating Treatment in First Through Third Relapse.2C | A MyCancerHaven™ Expert Roundtable: Navigating Treatment in First Through Third Relapse.

Will CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma? Dr. Samer Al Hadidi MD with Ravi VijWill CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma? Dr. Samer Al Hadidi MD with Ravi Vij

Ravi Vij, in Discussion with Dr. Nicholas Short MD on Incorporating Blincyto and Besponsa in ALLRavi Vij, in Discussion with Dr. Nicholas Short MD on Incorporating Blincyto and Besponsa in ALL

Subscribe to our “Conversations with Cancer Experts” Video Podcasts to keep up to date on the latestSubscribe to our “Conversations with Cancer Experts” Video Podcasts to keep up to date on the latest

Ravi Vij in Discussion with Dr. Nitya Nathwani MD on Choosing Between CAR-Ts & Bispecific AntibodiesRavi Vij in Discussion with Dr. Nitya Nathwani MD on Choosing Between CAR-Ts & Bispecific Antibodies

1D | A MyCancerHaven™ Expert Roundtable:NDMM: Looking Towards the Future1D | A MyCancerHaven™ Expert Roundtable:NDMM: Looking Towards the Future

Ravi Vij, in Discussion with Dr. Suresh Balasubramanian M.D, On Menin Inhibitors in Treatment of AMLRavi Vij, in Discussion with Dr. Suresh Balasubramanian M.D, On Menin Inhibitors in Treatment of AML

Ravi Vij, Discussing with Dr. Bita Fakhri MD, On Treatment of FrontLine Chronic Lymphocytic LeukemiaRavi Vij, Discussing with Dr. Bita Fakhri MD, On Treatment of FrontLine Chronic Lymphocytic Leukemia

Will CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma? Ravi Vij with Dr. Samer Al Hadidi MDWill CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma? Ravi Vij with Dr. Samer Al Hadidi MD

TopArticle.Ru
Статистика портала
Яндекс.Метрика
© 2008-2025 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения Пользовательское соглашение Соглашение о конфиденциальности Согласие на обработку персональных данных Информация для правообладателей Об использовании Cookies
salda.ws@mail.ru
Сейчас на сайте: 351 Статистика портала
Страницу в закладки Мои закладки
Все заметки Новая заметка Страницу в заметки